Testing a Device to Measure Inflammation in Children With Bowel Disease
Tests a nerve-response device to measure inflammation in children with Crohn disease or ulcerative colitis.
Plain-language title generated from the registry record
Registry title: Therapeutic Endpoint in Pediatric IBD Conditions
Key facts
- Where
- Washington D.C., United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 6 and 21 years old?
Source: NCT06065228, who can take part
Where in United States
- Children's National Health SystemWashington D.C., United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Children's National Research Institute
- Trial code
- NCT06065228
- Record updated
- 8 April 2026
- Original description
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.Read full original descriptionShow less
Development of a Therapeutic Endpoint in Pediatric IBD Conditions
The purpose of this clinical study is the development of physiologic endpoint of inflammation in pediatric patients diagnosed with inflammatory bowel disease (IBD), specifically subtypes Crohn's disease (CD) and ulcerative colitis (UC). The novel medical device evaluates the patient's sensory response to each of the three sensory nerve fiber types. Data from the device provides an assessment of disease activity and a more precise approach to treatment.
Inclusion: Male or female ≥ 6 years of age at screening; Documentation of an IBD diagnosis as evidenced by history.
Exclusion: Documented history of eye disease precluding pupillometry; Patients who are unwilling or unable to participate due to developmental delays or ongoing psychological diagnoses.